H1ssF Flu Vaccine Clinical Trial

Summary

This is a two-arm, open-label, randomized, phase 1, controlled clinical trial intended to evaluate the safety and immunologic response to the experimental vaccine H1ssF (H1 stabilized stem ferritin nanoparticle) and the seasonal flu vaccine Flucelvax.

Timeline

Start

2026-08-01

Primary completion

2028-03-01

Completion

2028-03-01

Outcome

Outcome not reported

Stopped (Enrollment): “Study did not open for enrollment. The principal investigator is moving to another institution, and next steps. The FDA IND has been withdrawn and the study has been closed with the UMN IRB.”

Drugs

Indications